Published in Br Med J on August 10, 1974
Pathway analysis reveals common pro-survival mechanisms of metyrapone and carbenoxolone after traumatic brain injury. PLoS One (2013) 1.44
Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut (1982) 1.05
Cimetidine: an advance in gastric ulcer treatment? Br Med J (1978) 1.04
Some aspects of medical management of gastrointestinal disease. I. Can Med Assoc J (1975) 0.97
Carbenoxolone-induced hypokalaemia simulating Guillain-Barré syndrome. Br Med J (1976) 0.92
Clinical picture of peptic ulceration diagnosed endoscopically. Gut (1977) 0.88
Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment. Br Med J (1977) 0.87
Focal Inflammation Causes Carbenoxolone-Sensitive Tactile Hypersensitivity in Mice. Open Pain J (2010) 0.83
Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects. Gut (1977) 0.82
Treatment of peptic ulcer disease- a symposium. West J Med (1977) 0.78
Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function. Int J Mol Sci (2017) 0.75
Current medical management of duodenal ulcer disease. Can Med Assoc J (1977) 0.75
TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS. Gut (1965) 5.25
Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut (1965) 4.56
Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation. Br Med J (1965) 3.94
Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut (1968) 3.46
Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone). Br Med J (1966) 3.20
Side effects of carbenoxolone sodium: a study of ambulant therapy of gastric ulcer. Gut (1967) 1.65
A double-blind trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer. Gut (1970) 1.53
Hypokalaemia complicating carbenoxolone (duogastrone) therapy. Br Med J (1969) 1.13
Hypokalemia after treatment with duogastrone (carbenoxolone). Br Med J (1969) 1.09
Biochemical effects of short-term treatment with carbenoxolone disodium. Br J Pharmacol Chemother (1966) 1.05
Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem (2008) 6.06
A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem J (1997) 5.86
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature (1991) 3.93
Nomenclature for sugar-binding subsites in glycosyl hydrolases. Biochem J (1997) 3.82
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med (1996) 3.21
Bowel function measurements of individuals with different eating patterns. Gut (1986) 2.92
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature (2001) 2.51
Structure of the nucleotide-diphospho-sugar transferase, SpsA from Bacillus subtilis, in native and nucleotide-complexed forms. Biochemistry (1999) 2.43
Central nervous pathways mediating angina pectoris. Lancet (1994) 2.38
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med (1994) 2.10
A census of carbohydrate-active enzymes in the genome of Arabidopsis thaliana. Plant Mol Biol (2001) 2.08
Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med (1991) 1.87
Biodegradation of explosives by transgenic plants expressing pentaerythritol tetranitrate reductase. Nat Biotechnol (1999) 1.86
The X6 "thermostabilizing" domains of xylanases are carbohydrate-binding modules: structure and biochemistry of the Clostridium thermocellum X6b domain. Biochemistry (2000) 1.84
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80
Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation (1993) 1.74
Altered bowel habit and menstruation. Lancet (1976) 1.73
Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71
Crystal structure of the type-2 Cu depleted laccase from Coprinus cinereus at 2.2 A resolution. Nat Struct Biol (1998) 1.70
Stress, social support and health-related behavior: a study of smoking, alcohol consumption and physical exercise. J Psychosom Res (1996) 1.70
Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69
Glycoside hydrolases and glycosyltransferases. Families, modules, and implications for genomics. Plant Physiol (2000) 1.67
Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67
Mortality in Crohn's disease. Q J Med (1980) 1.62
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57
pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57
[Not Available]. BioDrugs (1997) 1.56
Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Effect of theophylline on exercise-induced myocardial ischaemia. Lancet (1989) 1.52
Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry (1996) 1.52
The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51
Crystal structure of the catalytic domain of a bacterial cellulase belonging to family 5. Structure (1995) 1.46
Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46
Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44
Tuberculous pericarditis with rapid progression to constriction. Prompt diagnosis and treatment are needed. BMJ (1993) 1.43
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41
Very early prediction of restenosis after successful coronary angioplasty: anatomic and functional assessment. J Am Coll Cardiol (1990) 1.41
Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41
Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40
Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40
Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40
Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40
Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Etiology of gastric ulcer. Gastroenterology (1972) 1.37
The crystal structure of the catalytic core domain of endoglucanase I from Trichoderma reesei at 3.6 A resolution, and a comparison with related enzymes. J Mol Biol (1997) 1.37
Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36
Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36
'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33
Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol (1989) 1.32
Patellofemoral disorders: a classification system and clinical guidelines for nonoperative rehabilitation. J Orthop Sports Phys Ther (1998) 1.31
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol (1988) 1.31
Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29
Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29
Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations. N Engl J Med (1984) 1.28
Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods. Pediatr Cardiol (2000) 1.28
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. Nat Struct Biol (1996) 1.27
Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27
Three-dimensional structures of the Mn and Mg dTDP complexes of the family GT-2 glycosyltransferase SpsA: a comparison with related NDP-sugar glycosyltransferases. J Mol Biol (2001) 1.27
Structure of a family 15 carbohydrate-binding module in complex with xylopentaose. Evidence that xylan binds in an approximate 3-fold helical conformation. J Biol Chem (2001) 1.27
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
A comparison of three W170 protocols. Eur J Appl Physiol Occup Physiol (1977) 1.23
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis. J Pharm Pharmacol (1983) 1.22
Activity and specificity of human aldolases. J Mol Biol (1991) 1.21
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Br Med J (Clin Res Ed) (1983) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br J Clin Pharmacol (1984) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Clostridium thermocellum Xyn10B carbohydrate-binding module 22-2: the role of conserved amino acids in ligand binding. Biochemistry (2001) 1.19
Pectate lyase 10A from Pseudomonas cellulosa is a modular enzyme containing a family 2a carbohydrate-binding module. Biochem J (2001) 1.18
Structure of the Fusarium oxysporum endoglucanase I with a nonhydrolyzable substrate analogue: substrate distortion gives rise to the preferred axial orientation for the leaving group. Biochemistry (1996) 1.18
Coarse mucosal folds in the duodenum. Q J Med (1968) 1.18
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17